p53、Ki-67及E-cadherin在三阴性乳腺癌中表达的相关性研究
[Abstract]:Objective: to detect the expression of p53 Ki-67 and E-cadherin protein in (triple negative breast cancer,TNBC, non-triple-negative breast cancer (non-triple negative breast cancer,NTNBC), and to explore the relationship between the three markers and the clinicopathological features of TNBC. And the correlation between the expression of three proteins. The relationship between the expression of these three proteins and the prognosis of TNBC patients was analyzed. Methods: the expression of p53 Ki-67 and E-cadherin protein were detected by immunohistochemical staining in 52 cases of TNBC,52 with NTNBC. The relationship between the expression of p53 Ki-67 and the prognosis of TNBC was analyzed. Results: 1. The positive expression rate of p53 in TNBC was 67.3 and 44.2, respectively, which was higher than that in NTNBC (蠂 2 = 5.613). In TNBC, p53 positive expression was related to histological grade, tumor size and TNM stage (P0.05), but not to lymph node metastasis, age and menopausal status (P0.05). Survival curve showed that the overall survival rate of patients with p53 negative expression in TNBC was significantly higher than that of positive patients (P0.05). 2. The positive expression rate of Ki-67 in TNBCnTBC was 80.8% and 61.5%, respectively. The positive expression rate of Ki-67 in TNBC was higher than that in NTNBC (蠂 2 + 4.685% P0.030). In TNBC, the positive expression of Ki-67 was related to lymph node metastasis and TNM stage (P0.05), but not to tumor size, age, histological grade and menopausal status (P0.05). Survival curve showed that the overall survival rate of patients with negative expression of Ki-67 in TNBC was significantly higher than that of patients with positive expression (P0.05). 3. The positive expression rate of E-cadherin in NTNBC was 26.9% and 48.1%, respectively. The positive expression rate of E-cadherin in TNBC was lower than that in NTNBC (蠂 2 / 4.964). In TNBC, the positive expression of E-cadherin was related to tumor size, lymph node metastasis and TNM stage (P0.05), but not related to histological grade, age and menopausal status (P0.05). Survival curve showed that the overall survival rate of E-cadherin positive expression patients in TNBC was significantly higher than that of negative patients (P0.05). Survival curve showed that the overall survival rate of patients with p53 Ki-67 and E-cadherin positive co-expression in TNBC was significantly higher than that in p53 Ki-67 positive and E-cadherin negative co-expression (P0.05). In TNBC, the positive expression of p53 Ki-67 was positively correlated with that of p538, E-cadherin (r-0.686) and Ki-67,E-cadherin (r-0.584), and the expression of E-cadherin was negatively correlated with that of p53- 0.686, and that of Ki-67,E-cadherin was negatively correlated with that of p53-p538, E-cadherin and Ki-67,E-cadherin (r-0.584, r = 0.584), respectively. 6.Cox regression analysis showed that the tumor size, TNM stage, lymph node metastasis, p53, p53, The expression of Ki-67 and E-cadherin was a significant factor influencing the overall survival rate of patients with triple-negative breast cancer (P0.05). Cox regression analysis showed that the expression of p53 Ki-67 and E-cadherin was significant in patients with breast cancer. Lymph node metastasis was an independent prognostic factor for the overall survival rate of triple negative breast cancer patients (P0.05). Conclusion: 1. The expression of p53 Ki-67 is high in tri-negative breast cancer, and the prognosis of the patients with positive expression is poor; The prognosis of patients with low expression of E-cadherin in tri-negative breast cancer is poor. 2.p53 Ki-67 and E-cadherin may be involved in the occurrence, development, invasion and metastasis of tri-negative breast cancer. Combined detection of p53 Ki-67 and E-cadherin in tri-negative breast cancer may provide a new target for molecular therapy.
【学位授予单位】:江苏大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R737.9
【相似文献】
相关期刊论文 前10条
1 傅晨薇 ,郎景和;SERUM SOLUBLE E-CADHERIN LEVEL IN PATIENTS WITH ENDOMETRIOSIS[J];Chinese Medical Sciences Journal;2002年02期
2 夏红强;E-cadherin在肿瘤组织的检测及意义[J];临床肿瘤学杂志;2003年06期
3 ;Expression of TGF-β1,Snail,E-cadherin and N-cadherin in Gastric Cancer and Its Significance[J];Chinese Journal of Clinical Oncology;2007年06期
4 熊小蔚;崔明;;T-cadherin与肿瘤[J];医学综述;2010年08期
5 ;E-Cadherin在膀胱乳头状移行细胞癌的表达[J];国外医学(生理、病理科学与临床分册);1996年02期
6 张文军,张志谦,林仲翔,王耐勤,胡颖;Correlation between expression of cadherin and gap junctional communication in human lung carcinoma cells[J];Science in China(Series C:Life Sciences);1998年04期
7 ;The expression of N-cadherin/catenins/actin complex in human lung normal and carcinoma cells[J];Chinese Science Bulletin;1998年09期
8 ;Quantitative analysis of E-cadherin expression and clinicopathologic evaluation in gastric cancer[J];Chinese Medical Journal;1998年01期
9 Ge-Liang Liu;Han-Jie Yang;Tian Liu;Yun-Zhao Lin;;Expression and significance of E-cadherin,N-cadherin,transforming growth factor-β1 and Twist in prostate cancer[J];Asian Pacific Journal of Tropical Medicine;2014年01期
10 王曦,吴人亮,郝天玲,陈芳;Effects of Cigarette Smoke Extract on E-cadherin Expression in Cultured Airway Epithelial Cells[J];Journal of Tongji Medical University;2000年01期
相关会议论文 前10条
1 ;Core Fucosylation Regulates E-cadherin Binding Affinity in Human Lung Cancer Cells[A];2008年全国生物化学与分子生物学学术大会论文摘要[C];2008年
2 ;Epigenetic regulation of E-cadherin in HBV associate human Hepatocellular carcinoma[A];江苏省遗传学会第八届会员代表大会暨学术研讨会论文集[C];2010年
3 王冰晶;张志谦;;癌细胞cadherin亚型转变及其分子机制[A];中国细胞生物学学会2005年学术大会、青年学术研讨会论文摘要集[C];2005年
4 ;Suppressed survival and proliferation of ovarian cancer cells by repressed MEK-ERK activation via knocking-down of E-cadherin[A];中华医学会肿瘤学分会第七届全国中青年肿瘤学术会议——中华医学会肿瘤学分会“中华肿瘤 明日之星”大型评选活动暨中青年委员全国遴选论文汇编[C];2011年
5 ;N-cadherin:a potential receptor of GDNF[A];Proceedings of the 8th Biennial Conference of the Chinese Society for Neuroscience[C];2009年
6 Zhiyang Xu;Dechang Li;Baohua Ji;;Quantification of the stiffness and strength of cadherin ectodomain binding with different ions[A];北京力学会第20届学术年会论文集[C];2014年
7 贾文亮;张庆瑜;;关于E-cadherin在胃癌和肺癌中表达情况的研究[A];天津市生物医学工程学会第三十三届学术年会论文集[C];2013年
8 乌新春;倪志超;段昕所;宋有鑫;;绿色荧光蛋白标记的T-cadherin基因稳定转染黑素瘤细胞株的建立[A];第五届全国中医药免疫学术研讨会——暨环境·免疫与肿瘤防治综合交叉会议论文汇编[C];2009年
9 ;Manipulation of N-cadherin level and function through different methods results in distinct functional changes in hippocampal neurons[A];Proceedings of the 7th Biennial Meeting and the 5th Congress of the Chinese Society for Neuroscience[C];2007年
10 张宪真;陈随芹;耿秀东;;N-Cadherin与E-Cadherin在非小细胞肺癌中的表达及相关性研究[A];中国肿瘤内科进展 中国肿瘤医师教育(2014)[C];2014年
相关博士学位论文 前10条
1 杨俊俊;Rab5 GTPase介导的VE-cadherin内吞调控肺微血管内皮细胞屏障功能的机制[D];第三军医大学;2015年
2 张红燕;STAT3/ZEB1/E-cadherin信号轴在食管鳞癌上皮间质转化中的作用及机制研究[D];郑州大学;2016年
3 陶祥;SNAI2—E-cadherin轴在LRIG1调节人脑胶质瘤细胞侵袭和转移中的作用研究[D];武汉大学;2016年
4 王唯一;双氢青蒿素对喉癌干细胞侵袭和转移的影响及其相关机制研究[D];河北医科大学;2017年
5 宋小珍;Par3-aPKC与Vangl2相互作用并参与调节E-cadherin-based粘附连接和管腔化形成[D];北京协和医学院;2017年
6 马福哲;12-脂氧化酶对糖尿病肾病肾小球P-cadherin表达的影响及其机制研究[D];吉林大学;2017年
7 瞿金妙;E-cadherin,,CD44和MSH2相关的列线图预测Ⅱ和Ⅲ期结直肠癌预后[D];南方医科大学;2017年
8 冯海燕;鼻咽癌中R-cadherin基因的表观沉默机制及抑癌功能研究[D];广西医科大学;2010年
9 黎景佳;E-cadherin在喉鳞状细胞癌中的表达及其与肿瘤侵袭转移的关系[D];中南大学;2010年
10 吴扬;VE-cadherin重组腺病毒偶联氧化型甘露聚糖抗肿瘤实验研究[D];四川大学;2005年
相关硕士学位论文 前10条
1 衷灿梅;12-脂氧合酶通过上皮间质转化促进胃癌侵袭转移的机制研究[D];福建医科大学;2015年
2 高玉梅;探索N-cadherin在卵巢癌发生和进展中的作用及意义[D];石河子大学;2015年
3 林路;E-cadherin,β-catenin,N-cadherin在浆液性卵巢癌中的表达及意义[D];安徽医科大学;2015年
4 辛明;Galectin-3通过EGFR介导调控肿瘤细胞E-cadherin表达的机制研究[D];山东大学;2015年
5 孟梅;VE-cadherin对血管稳态的作用及调控机制[D];苏州大学;2015年
6 汪威;丙泊酚对荷瘤大鼠MADB106肿瘤细胞肺转移及E-cadherin和β-catenin的影响[D];南方医科大学;2015年
7 孙琳;ALCAM、E-cadherin和β-catenin在甲状腺乳头状癌中的表达及意义[D];河北医科大学;2014年
8 于海峰;FOXQ1和E-cadherin在食管鳞状细胞癌中的表达及临床意义[D];天津医科大学;2015年
9 何宏月;EMT相关蛋白E-cadherin、N-cadherin、Snail和Slug在子宫内膜异位症中的表达及意义[D];天津医科大学;2015年
10 刘超;EMX2和E-cadherin在食管鳞癌中的表达及临床病理意义[D];天津医科大学;2015年
本文编号:2385658
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2385658.html